Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.

Journal of Cellular and Molecular Medicine
Angel Cedazo-Mínguez

Abstract

Multiple genetic and environmental factors are likely to contribute to the development of Alzheimer's disease (AD). The most important known risk factor for AD is presence of the E4 isoform of apolipoprotein E (apoE). Epidemiological studies demonstrated that apoE4 carriers have a higher risk and develop the disease and an early onset. Moreover, apoE4 is the only molecule that has been associated with all the biochemical disturbances characteristic of the disease: amyloid-beta (Abeta) deposition, tangle formation, oxidative stress, lipid homeostasis deregulation, synaptic plasticity loss and cholinergic dysfunction. This large body of evidence suggest that apoE is a key player in the pathogenesis of AD. This short review examines the current facts and hypotheses of the association between apoE4 and AD, as well as the therapeutic possibilities that apoE might offer for the treatment of this disease.

References

Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M J IgnatiusE M Shooter
Jan 13, 1987·Biochimica Et Biophysica Acta·R E PitasR W Mahley
Jul 28, 1995·Neuroscience Letters·T UchiharaJ J Hauw
May 16, 1994·Biochemical and Biophysical Research Communications·H HartmannW E Müller
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D E SchmechelA D Roses
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·J PoirierS Gauthier
Jan 17, 1996·Annals of the New York Academy of Sciences·R W MahleyR E Pitas
May 1, 1997·Journal of the Neurological Sciences·F BaskinR N Rosenberg
Jun 12, 1998·Brain Research. Brain Research Reviews·U BeffertJ Poirier
Feb 23, 1999·The American Journal of Pathology·P T XuD E Schmechel
Mar 17, 1999·The Journal of Clinical Investigation·D M HoltzmanS M Paul
May 21, 1999·Neuroscience·I Veinbergs, E Masliah
Aug 10, 1999·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·A E RoherS Gracon
Dec 22, 1999·Neurobiology of Disease·U BoschertS Catsicas
Dec 22, 1999·Neurobiology of Aging·C E Finch, R M Sapolsky
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·K R BalesS M Paul
Feb 15, 2000·Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology·J Poirier
Nov 23, 2000·Lancet·H JickD A Drachman
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·E KojroF Fahrenholz
May 5, 2001·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·T Arendt
Jul 12, 2001·Proceedings of the National Academy of Sciences of the United States of America·Y HuangR W Mahley
Aug 24, 2001·Journal of Molecular Biology·C M YipJ McLaurin
Feb 19, 2002·Neurobiology of Disease·Suzanne WahrleTodd E Golde
Jun 6, 2002·European Biophysics Journal : EBJ·Danny M Hatters, Geoffrey J Howlett
Jan 8, 2003·The Journal of Cell Biology·Robert EhehaltKai Simons

❮ Previous
Next ❯

Citations

Nov 7, 2008·The British Journal of Nutrition·Christine Boesch-SaadatmandiGerald Rimbach
Oct 13, 2009·Psychological Medicine·M GillA Corvin
Nov 27, 2008·The Journal of Clinical Investigation·Rashid DeaneBerislav V Zlokovic
Oct 1, 2008·BMC Biotechnology·Suzanne ZeitouniDarwin J Prockop
May 15, 2010·Journal of Lipid Research·Ingemar BjörkhemSteve Meaney
Jun 14, 2012·PloS One·Rachel D SchrierUNKNOWN HNRC Group
Dec 16, 2011·The American Journal of Clinical Nutrition·May A BeydounAlan B Zonderman
Apr 3, 2014·Trends in Neurosciences·David A Raichlen, Gene E Alexander
Nov 12, 2015·International Journal of Molecular Sciences·Takashi AmemoriEva Sykova
Sep 2, 2009·Neuroscience and Biobehavioral Reviews·Lee-Fay LowHenry Brodaty
Mar 7, 2009·Journal of the Neurological Sciences·Bogdan O PopescuNenad Bogdanovic
Jul 23, 2009·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Karsten RuscherTadeusz Wieloch
Sep 11, 2009·Topics in Stroke Rehabilitation·Kristin M Pearson-FuhrhopSteven C Cramer
May 16, 2014·Molecular Neurobiology·Vishal Jindal
Apr 23, 2010·Neurobiology of Aging·Aaron J TrachtenbergClare E Mackay
Jun 16, 2010·Neuroscience and Biobehavioral Reviews·R A F WeijenbergF Lobbezoo
Oct 4, 2013·Pharmacogenomics·Kristin M Pearson-Fuhrhop, Steven C Cramer
Sep 22, 2016·Frontiers in Neuroendocrinology·Mariana F UchoaChristian J Pike
Oct 6, 2012·American Journal of Alzheimer's Disease and Other Dementias·Saliha Handan YildizEvrim Suna Arikan Terzi
Feb 14, 2014·Molecular Genetics and Genomics : MGG·Yiran XuQinghe Xing
Dec 31, 2016·Journal of Alzheimer's Disease : JAD·Torbjörn PerssonÁngel Cedazo-Mínguez
Dec 3, 2010·The EPMA Journal·Iris GrossmanAllen D Roses
Mar 15, 2018·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Jennifer L EtnierLaurie Wideman
Feb 9, 2011·PM & R : the Journal of Injury, Function, and Rehabilitation·Kristin M Pearson-Fuhrhop, Steven C Cramer
May 19, 2009·Journal of Cellular and Molecular Medicine·John KorenChad A Dickey
Jan 6, 2010·Journal of Neurochemistry·Ian J MartinsRalph N Martins
Nov 26, 2009·Journal of Cellular and Molecular Medicine·Marina HermesOlga Garaschuk
Feb 18, 2010·Journal of Cellular and Molecular Medicine·Per NilssonTakaomi C Saido
Mar 28, 2008·Journal of Cellular and Molecular Medicine·Kurt A JellingerElisabeth Kienzl
Sep 29, 2011·CNS Neuroscience & Therapeutics·Arezoo AssarehPerminder S Sachdev
Apr 22, 2014·Journal of Internal Medicine·J HardyH Zetterberg
Dec 3, 2014·Aging Cell·Silvia MaioliUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 11, 2017·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Miguel MedinaAngel Cedazo-Minguez
May 10, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Jeffrey L Cummings

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.